MSFT   183.48 (+0.29%)
GOOGL   1,430.09 (+0.84%)
AMZN   2,420.04 (+0.79%)
NVDA   346.39 (+2.03%)
CGC   17.57 (-19.11%)
MU   47.59 (+2.41%)
GE   6.64 (-2.21%)
TSLA   823.17 (+2.15%)
AMD   52.70 (+1.84%)
ACB   14.13 (-7.89%)
DIS   117.36 (+0.52%)
NFLX   415.92 (+0.60%)
BAC   24.70 (-0.64%)
MSFT   183.48 (+0.29%)
GOOGL   1,430.09 (+0.84%)
AMZN   2,420.04 (+0.79%)
NVDA   346.39 (+2.03%)
CGC   17.57 (-19.11%)
MU   47.59 (+2.41%)
GE   6.64 (-2.21%)
TSLA   823.17 (+2.15%)
AMD   52.70 (+1.84%)
ACB   14.13 (-7.89%)
DIS   117.36 (+0.52%)
NFLX   415.92 (+0.60%)
BAC   24.70 (-0.64%)
MSFT   183.48 (+0.29%)
GOOGL   1,430.09 (+0.84%)
AMZN   2,420.04 (+0.79%)
NVDA   346.39 (+2.03%)
CGC   17.57 (-19.11%)
MU   47.59 (+2.41%)
GE   6.64 (-2.21%)
TSLA   823.17 (+2.15%)
AMD   52.70 (+1.84%)
ACB   14.13 (-7.89%)
DIS   117.36 (+0.52%)
NFLX   415.92 (+0.60%)
BAC   24.70 (-0.64%)
MSFT   183.48 (+0.29%)
GOOGL   1,430.09 (+0.84%)
AMZN   2,420.04 (+0.79%)
NVDA   346.39 (+2.03%)
CGC   17.57 (-19.11%)
MU   47.59 (+2.41%)
GE   6.64 (-2.21%)
TSLA   823.17 (+2.15%)
AMD   52.70 (+1.84%)
ACB   14.13 (-7.89%)
DIS   117.36 (+0.52%)
NFLX   415.92 (+0.60%)
BAC   24.70 (-0.64%)
Log in

NYSE:RMDResMed Stock Price, Forecast & News

$159.05
+0.23 (+0.14 %)
(As of 05/29/2020 03:03 PM ET)
Add
Compare
Today's Range
$157.09
Now: $159.05
$161.74
50-Day Range
$153.68
MA: $161.10
$169.28
52-Week Range
$108.85
Now: $159.05
$177.99
Volume29,607 shs
Average Volume666,108 shs
Market Capitalization$23.01 billion
P/E Ratio45.06
Dividend Yield1.01%
Beta0.5
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; and myAir, a patient engagement application that provides sleep data and a daily score based on their previous night's data, as well as offers business management software and services to medical equipment and home health providers. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Read More
ResMed logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 1.8Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.96 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP76115210
Phone858-836-5000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.61 billion
Cash Flow$4.88 per share
Book Value$15.60 per share

Profitability

Net Income$404.59 million

Miscellaneous

Employees7,240
Market Cap$23.01 billion
Next Earnings Date7/23/2020 (Estimated)
OptionableOptionable

Receive RMD News and Ratings via Email

Sign-up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter.

ResMed (NYSE:RMD) Frequently Asked Questions

How has ResMed's stock been impacted by COVID-19 (Coronavirus)?

ResMed's stock was trading at $153.61 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RMD shares have increased by 3.5% and is now trading at $159.05. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of ResMed?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ResMed in the last year. There are currently 2 sell ratings, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for ResMed.

When is ResMed's next earnings date?

ResMed is scheduled to release its next quarterly earnings announcement on Thursday, July 23rd 2020. View our earnings forecast for ResMed.

How were ResMed's earnings last quarter?

ResMed Inc. (NYSE:RMD) released its quarterly earnings data on Thursday, April, 30th. The medical equipment provider reported $1.29 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.00 by $0.29. The medical equipment provider earned $769.50 million during the quarter, compared to analyst estimates of $717.70 million. ResMed had a return on equity of 29.26% and a net margin of 17.73%. The business's revenue was up 16.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.89 EPS. View ResMed's earnings history.

How often does ResMed pay dividends? What is the dividend yield for ResMed?

ResMed declared a quarterly dividend on Thursday, April 30th. Shareholders of record on Thursday, May 14th will be paid a dividend of $0.39 per share on Thursday, June 18th. This represents a $1.56 annualized dividend and a yield of 0.98%. The ex-dividend date is Wednesday, May 13th. View ResMed's dividend history.

What price target have analysts set for RMD?

10 Wall Street analysts have issued 12-month price objectives for ResMed's stock. Their forecasts range from $165.00 to $200.00. On average, they anticipate ResMed's stock price to reach $179.67 in the next year. This suggests a possible upside of 13.0% from the stock's current price. View analysts' price targets for ResMed.

Has ResMed been receiving favorable news coverage?

News articles about RMD stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ResMed earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutResMed.

Are investors shorting ResMed?

ResMed saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,820,000 shares, an increase of 6.4% from the April 15th total of 1,710,000 shares. Based on an average daily volume of 821,800 shares, the short-interest ratio is presently 2.2 days. Approximately 1.3% of the company's stock are short sold. View ResMed's Current Options Chain.

Who are some of ResMed's key competitors?

What other stocks do shareholders of ResMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ResMed investors own include NVIDIA (NVDA), Netflix (NFLX), Walt Disney (DIS), QUALCOMM (QCOM), Adobe (ADBE), Visa (V), Advanced Micro Devices (AMD), Alibaba Group (BABA), Intel (INTC) and salesforce.com (CRM).

Who are ResMed's key executives?

ResMed's management team includes the following people:
  • Mr. Michael J. Farrell BE, SM, MBA, CEO & Director (Age 47)
  • Mr. Robert A. Douglas, Pres & COO (Age 59)
  • Mr. Brett A. Sandercock, Chief Financial Officer (Age 52)
  • Mr. David B. Pendarvis, Chief Admin. Officer, Global Gen. Counsel & Sec. (Age 60)
  • Mr. James Hollingshead, Pres of Sleep Bus. (Age 56)

What is ResMed's stock symbol?

ResMed trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMD."

Who are ResMed's major shareholders?

ResMed's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.54%), WCM Investment Management LLC (5.65%), State Street Corp (4.60%), Capital World Investors (3.83%), Baillie Gifford & Co. (3.13%) and Geode Capital Management LLC (1.70%). Company insiders that own ResMed stock include Brett Sandercock, David Pendarvis, James Hollingshead, John P Wareham, Michael J Farrell, Rajwant Sodhi, Richard Mchale, Richard Sulpizio, Robert Andrew Douglas and Ronald R Taylor. View institutional ownership trends for ResMed.

Which institutional investors are selling ResMed stock?

RMD stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Capital World Investors, Retirement Systems of Alabama, Canada Pension Plan Investment Board, Voloridge Investment Management LLC, APG Asset Management N.V., and Blair William & Co. IL. Company insiders that have sold ResMed company stock in the last year include Brett Sandercock, David Pendarvis, James Hollingshead, Michael J Farrell, Rajwant Sodhi, Richard Mchale, Robert Andrew Douglas, and Ronald R Taylor. View insider buying and selling activity for ResMed.

Which institutional investors are buying ResMed stock?

RMD stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., WCM Investment Management LLC, BlackRock Inc., State Street Corp, Sumitomo Mitsui Trust Holdings Inc., Zurich Insurance Group Ltd FI, Robeco Institutional Asset Management B.V., and Swiss National Bank. View insider buying and selling activity for ResMed.

How do I buy shares of ResMed?

Shares of RMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ResMed's stock price today?

One share of RMD stock can currently be purchased for approximately $159.05.

How big of a company is ResMed?

ResMed has a market capitalization of $23.01 billion and generates $2.61 billion in revenue each year. The medical equipment provider earns $404.59 million in net income (profit) each year or $3.64 on an earnings per share basis. ResMed employs 7,240 workers across the globe.

What is ResMed's official website?

The official website for ResMed is www.resmed.com.

How can I contact ResMed?

ResMed's mailing address is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-836-5000 or via email at [email protected]

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.